regress-hfpef
Cell therapyexperimental
Clinical trial activity
2 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Oct 1, 2016 (NCT02941705)
Timeline
Indications
Mechanism of action
- Unspecified targetTissue restoration
Tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- regress-hfpef
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05949801 | Phase 3 | Apr 13, 2023 | Capital Medical University, Chinese Academy of Medical Sciences, Zensun |
| NCT02941705 | Phase 2 | Oct 1, 2016 | Cedars-Sinai Medical Center, Medical University of South Carolina, University of South Carolina |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Capital Medical University | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Cedars-Sinai Medical Center | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Medical University of South Carolina | Academic/Hospital | 1 | 0 | 1 | 2016 |
| University of South Carolina | Academic/Hospital | 1 | 1 | 1 | 2016 |
| Zensun | For profit | 1 | 1 | 1 | 2023 |
6 organizations
Page 1 / 1